Amarin (AMRN) Profit Margin (2013 - 2026)
Amarin (AMRN) profit margin from Mar 31, 2013 to Mar 31, 2026. The current Amarin (AMRN) profit margin is -23.29%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Profit Margin
Quarterly Profit Margin
Annual Profit Margin change of Amarin (AMRN)
| Year | Profit Margin | Change |
|---|---|---|
| 2025 | -18.16% | -49.48% |
| 2024 | -35.95% | +86.65% |
| 2023 | -19.26% | -32.79% |
| 2022 | -28.66% | -2262.05% |
| 2021 | 1.33% | -145.22% |
| 2020 | -2.93% | -44.36% |
| 2019 | -5.27% | -89.63% |
| 2018 | -50.80% | +14.85% |
| 2018 | -44.23% | -31.94% |
| 2018 | -64.99% | +18.48% |
| 2018 | -54.85% | +46.38% |
| 2017 | -37.47% | +64.01% |
| 2017 | -22.85% | -24.17% |
| 2017 | -30.13% | -50.16% |
| 2017 | -60.45% | -8.94% |
| 2016 | -66.38% | +37.77% |
| 2016 | -48.18% | +19.50% |
| 2016 | -40.32% | -65.41% |
| 2016 | -116.56% | -17.27% |
| 2015 | -140.90% | -6.36% |
| 2015 | -150.47% | -25.07% |
| 2015 | -200.82% | +93.12% |
| 2014 | -103.99% | -43.52% |
| 2014 | -184.10% | -251.53% |
| 2014 | 121.49% | -151.30% |
| 2014 | -236.83% | -62.46% |
| 2013 | -630.85% | +8.41% |
| 2013 | -581.90% | -19.53% |
| 2013 | -723.09% | -72.78% |
| 2013 | -2656.41% | N/A |
Comparison Amarin (AMRN) profit margin with competitors
Amarin (AMRN) profit margin is -23.29%.
| Ticker | Name | Profit Margin | Upside |
|---|---|---|---|
| NVO | Novo Nordisk | 50.15% | -315.34% |
| LLY | Lilly(Eli) & Company | 37.36% | -260.42% |
| GILD | Gilead Sciences Inc | 29.04% | -224.70% |
| NVS | Novartis AG | 23.34% | -200.22% |
| BMY | Bristol-Myers Squibb Company | 23.30% | -200.05% |
| GSK | GSK Plc | 22.77% | -197.77% |
| JNJ | Johnson & Johnson | 21.76% | -193.44% |
| AMGN | AMGEN Inc | 21.11% | -190.65% |
| AZN | Astrazeneca plc | 20.15% | -186.52% |
| PFE | Pfizer Inc | 18.59% | -179.83% |
| SNY | Sanofi | 14.35% | -161.62% |
| BIIB | Biogen Inc | 12.89% | -155.35% |
| OGN | Organon & Company | 10.00% | -142.94% |
| ABBV | Abbvie Inc | 4.63% | -119.88% |
| GRFS | Grifols SA | 4.29% | -118.42% |